E208 - Pharmacological management of attention deficit hyperactivity disorder in adults

In a follow-up to our episode on attention deficit hyperactivity disorder (ADHD) in children and adolescents, Justin Coleman talks to psychiatrist Shuichi Suetani about the pharmacological management of ADHD in adults. They discuss the different considerations for managing adults compared with children, as well as important adverse effects and monitoring of ADHD medications. Shuichi also outlines other factors to consider when assessing treatment response. Read the full article in Australian Prescriber.

Jo Cheah talks to Terri-Lynne South, Medical Director at Lifestyle Metabolic in Brisbane, about her paper on injectable drugs for weight management. Terri-Lynne outlines the available GLP-1 drugs and how they work in managing weight. The conversation also covers important considerations for prescribers, including off-label use, potential adverse effects and the need for behavioural and lifestyle modifications. Read the full article by Terri-Lynne and her co-author Natasha Yates in Australian Prescriber.

Justin Coleman chats with sexual health physician Louise Owen about her paper on HIV testing. The conversation covers who and when to test, including higher risk populations and indicator conditions, and the types of HIV tests available, such as rapid point-of-care testing. Read the full article in Australian Prescriber.

AP Podcast hosts David Liew and Dhineli Perera talk about Australia's top 10 drugs over the last year. They discuss the top drugs dispensed under the PBS, based on prescription count and cost to the government. They touch on changes to the use of certain drug classes such as oral anticoagulation, and the impact of the COVID pandemic on antiviral drug use. Read the full article for 2024-25 in Australian Prescriber.

Jo Cheah speaks to clinical pharmacologist Paul Chin about safe use of direct oral anticoagulants and warfarin for adults with atrial fibrillation or venous thromboembolism. They talk about dosing in renal impairment and extremes of body weight, drug interactions, anticoagulant assays, when to use anticoagulant antidotes and when to consult an anticoagulant service. Read the full article in Australian Prescriber.

Justin Coleman chats with paediatrician Daryl Efron about his paper on the pharmacological management of attention deficit hyperactivity disorder (ADHD) in children and adolescents. They discuss the role of stimulants and non-stimulants, starting and stopping treatment, and monitoring for adverse effects. Read the full paper in Australian Prescriber.

Laura Beaton talks to endocrinologist Chris Nolan about the new Australasian consensus recommendations on the screening and diagnosis of gestational diabetes. The conversation covers changes to diagnostic thresholds, indications for early testing, and pharmacological therapies. Read the full article in Australian Prescriber.

David Liew speaks with endocrinologists Faran Khalili and Morton Burt about their article on practical guidance for stopping glucocorticoids. The discussion includes common glucocorticoids used in Australia, when to stop abruptly versus when to taper, recognising adrenal insufficiency and sick day management. Read the full article in Australian Prescriber.

Justin Coleman chats to Lee Fong, member of the Oral and Dental Expert Group, about some of the updates in the latest version of Therapeutic Guidelines: Oral and Dental. With a focus on GP management of dental issues, the conversation includes discussion of preventative steps, oral risks during pregnancy, oral mucosal diseases, acute infections and much more.

Dhineli Perera talks to infectious diseases physician and clinical microbiologist Carly Hughes about the latest recommendations for aminoglycoside use in Australia. They discuss indications for parenteral aminoglycosides, drug selection, dosing and therapeutic drug monitoring. Read the full article by Carly and her co-authors in Australian Prescriber.